Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$167.33 USD
+2.59 (1.57%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $167.32 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/21/2025
Time: -- |
9/2025 | $2.78 | 0.00% |
Earnings Summary
For their last quarter, Johnson & Johnson (JNJ) reported earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 per share. This reflects a positive earnings surprise of 4.14%. Look out for JNJ's next earnings release expected on October 21, 2025. For the next earning release, we expect the company to report earnings of $2.78 per share, reflecting a year-over-year increase of 14.88%.
Earnings History
Price & Consensus
Zacks News for JNJ
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns
TEVA Q2 Earnings Beat, Revenues Miss on Lower Generics Sales
AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised '25 EPS View
JNJ FAQs
Johnson & Johnson (JNJ) has announced they will report their next quarter earnings on October 21, 2025. For the next earning release, we expect the company to report earnings of $2.78 per share, reflecting a year-over-year increase of 14.88%.
Johnson & Johnson has announced they will report their previous quarter earnings after the close of the market on October 21, 2025.
The Zacks Consensus Estimate for Johnson & Johnson (JNJ) for the quarter ending September 2025 is $2.78 a share. We expect Johnson & Johnson (JNJ) to report earnings in line with the consensus estimate of $2.78 per share
In the earnings report for the quarter ending in September 2024, Johnson & Johnson (JNJ) announced earnings of $2.42 per share versus the Zacks Consensus Estimate of $2.22 per share, representing a surprise of 9.01%.